CERC acquires GNMX for $0.134/sh in stock plus a CVR: https://www.globenewswire.com/news-release/2019/12/05/1956803/0/en/Cerecor-to-Acquire-Aevi-Genomic-Medicine.html This is a fire sale with no premium. The nominal deal value (excluding the CVR) is $16.1M.